The global animal model market size was valued at approximately $1.4 billion in 2021 and is projected to reach approximately $2.5 billion by 2028, expanding at a CAGR of 6% over the forecast period. This report will cover the complete market overview, growth drivers, opportunities, and challenges for the animal model market between 2022 and 2028.
Global Animal Model Market: Overview
The animal model refers to the animals utilised in biological and pathological research. They are used as test subjects before being administered to humans. There are protocols and guidelines that must be followed when using animal models in research.
Animals and humans have comparable biological and physiological structures. Even though animals have shorter lifespans, their genotypes are so similar that the results are comparable. Even the organic structure of these animals is comparable to that of humans. Scientists and researchers discover a cure for any disease by testing medicinal components on animals until their experiment is successful. In addition, they create new products based on the results of these experiments.
These drugs that are tested on animals are also validated for their recovery efficacy. These animal model tests also determine the level of safety of the medications. They have applications in all fields, including R&D, production, quality assurance, and academia.
Get a FREE PDF: https://www.zionmarketresearch.com/sample/animal-model-market
Global Animal Models Market : Growth Drivers
The growth of the market is driven by the expansion of the pharmaceutical and drug discovery industries.
Due to the rise of multiple diseases and chronic illnesses, drug discovery and the development of vaccinations have increased exponentially in recent decades. This has accelerated the development of new treatment methods and medications by scientists and researchers. Due to these factors, animal model testing has increased rapidly, thereby substantially accelerating the global market rate.
Researchers from around the globe are concentrating on genetically modified models in order to improve the results of any testing. To achieve accuracy, the metabolic processes, life processes, and organic structures of the testing animals must mirror those of humans. This factor contributes exclusively to the revenue growth.
Cancer disease has become more prevalent in a number of regions, necessitating rigorous testing of potential cancer treatments using animal models. Research grants and government initiatives that support such a mission contribute to the expansion of the animal model market in all regions. The prevalence of the elderly population and the prevalence of chronic illness among the elderly are also excellent market drivers.
Additionally, animal models are utilised to comprehend the severity of diseases and their associated symptoms. With the aid of animal models, the efficacy of vaccinations and prevention procedures is also deduced to a significant degree. These factors provide a substantial boost to the development of healthcare sectors, thereby driving market expansion.
Global Animal Model Market: Opportunities
Opportunities for market expansion are afforded by the expansion of the healthcare industry and methods for enhancing the accuracy of test results.
The global animal model market is afforded lucrative opportunities by the growth prospects in the healthcare industry and the development of innovative techniques for achieving testing precision. Government support for the development of standard protocols and animal model testing for the treatment of new diseases presents exceptional opportunities for market growth.
Animal Model Market: Segmentation
The global market for animal models is segmented according to animal type, technology, application, end user, and region. The types of animals include pigs, cats, and mice. Applications are categorised as research, development, production, and quality assurance. Research institutes, educational institutes, pharmaceutical institutes, and contract research organisations are the end-users.
Recent Developments:
- Horizon Discovery Group created and developed IgM antibodies and obtained a licence for an animal model testing commercial agreement in April 2021.
- Mammoth Bioscience obtained a new license for the generation of CHO cells using mice testing procedures in October 2020.
This comment has been removed by the author.
ReplyDelete